# HCP Plastene (NSE: HPBL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/HPBL · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹243 Cr, it ranks 2166th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Packaging & Containers.

Its return on equity was 28.3% in FY26. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹143 Cr (+16.8% year on year) and net profit ₹8 Cr (+21.3%), on a consolidated basis. Promoters held 75.00% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹243 Cr |
| ROE | 28.3% (FY26) |
| ROCE | 35.8% (FY26) |
| Debt to equity | 2.98 |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹143 Cr | +16.8% | ₹8 Cr | +21.3% | ₹7.82 |
| Q3 FY26 | ₹121 Cr | +1.6% | ₹8 Cr | +278.6% | ₹7.80 |
| Q2 FY26 | ₹198 Cr | +68.9% | ₹5 Cr | +130.0% | ₹4.67 |
| Q1 FY26 | ₹126 Cr | +20.1% | ₹7 Cr | +234.9% | ₹6.70 |
| Q4 FY25 | ₹122 Cr | +59.6% | ₹7 Cr | +466.9% | ₹6.23 |
| Q3 FY25 | ₹119 Cr | +49.8% | ₹2 Cr | +685.7% | ₹2.10 |
| Q2 FY25 | ₹117 Cr | +48.4% | ₹2 Cr | +126.0% | ₹2.25 |
| Q1 FY25 | ₹105 Cr | +76.4% | ₹2 Cr | — | ₹1.99 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹463 Cr | ₹13 Cr |
| FY24 | ₹295 Cr | ₹0 Cr |
| FY23 | ₹352 Cr | ₹1 Cr |
| FY22 | ₹112 Cr | −₹2 Cr |
| FY21 | ₹16 Cr | ₹64 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 75.00%
- Foreign institutions: 2.67%
- Domestic institutions: 4.69%
- Non-institutions: 17.64%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Chembond Material Technologies](https://app.pivotnow.in/stock/CHEMBOND) | ₹191.00 | ₹257 Cr | 19.9 | — |
| [Sikko Industries](https://app.pivotnow.in/stock/SIKKO) | ₹5.77 | ₹252 Cr | 48.1 | — |
| [Star Paper Mills](https://app.pivotnow.in/stock/STARPAPER) | ₹160.00 | ₹250 Cr | 7.6 | — |
| [DCM Shriram Fine Chemicals](https://app.pivotnow.in/stock/DSFCL) | ₹28.68 | ₹249 Cr | — | — |
| [Tierra Agrotech](https://app.pivotnow.in/stock/TIERRA) | — | ₹247 Cr | — | — |
| [Shankar Lal Rampal Dye-Chem](https://app.pivotnow.in/stock/SRD) | ₹37.80 | ₹242 Cr | 17.9 | — |

## Questions and answers

### What is the market cap of HCP Plastene?

HCP Plastene's market capitalisation is ₹243 Cr (₹243 Cr) at the 19 Oct 2026 close, ranking 2166th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of HCP Plastene?

Return on equity was 28.3% in FY26 and return on capital employed was 35.8% in FY26 (consolidated figures).

### Is HCP Plastene a debt-free company?

No. HCP Plastene's debt-to-equity ratio was 2.98 in FY26, with total debt of ₹55 Cr.

### What were HCP Plastene's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), HCP Plastene reported revenue of ₹143 Cr, +16.8% year on year, and net profit of ₹8 Cr, +21.3% year on year.

### What is the shareholding pattern of HCP Plastene?

As of 30 Jun 2026: promoters 75.00%, foreign institutions 2.67%, domestic institutions 4.69%, non-institutions 17.64%.

### Who are HCP Plastene's competitors?

The listed Cement & Materials companies closest to HCP Plastene by market cap are Chembond Material Technologies, Sikko Industries, Star Paper Mills, DCM Shriram Fine Chemicals, Tierra Agrotech and Shankar Lal Rampal Dye-Chem.

### Is HCP Plastene a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out HCP Plastene's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on HPBL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.